49 results
8-K
9619mxfz30dkd9ult6cu
27 Jun 23
Edesa Biotech Appoints Biotech Deal Veteran to CFO Role
4:45pm
8-K
EX-10.1
3ffetggz365u epln
27 Jun 23
Edesa Biotech Appoints Biotech Deal Veteran to CFO Role
4:45pm
424B5
fqf3085m
23 Mar 22
Prospectus supplement for primary offering
4:09pm
8-K
EX-4.3
wwtomlz q7in4
23 Mar 22
Edesa Biotech Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:05pm
8-K
EX-1.1
18soa
22 Nov 21
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-10.1
jmpnen9gvrc4
22 Mar 21
Entry into a Material Definitive Agreement
8:00am
424B5
o6sayw0
26 Feb 21
Prospectus supplement for primary offering
4:13pm
8-K/A
EX-1.1
1ft6xita
26 Feb 21
Edesa Biotech Announces $3.5 Million Bought Deal Offering of Common Shares
4:10pm
424B5
1idyljb88 0dxfao2pmy
25 Feb 21
Prospectus supplement for primary offering
4:48pm
8-K
EX-10.1
wres zqjt
3 Feb 21
Edesa Biotech Receives C$14 million for COVID-19 Study
8:00am